Wire
Sana Biotechnology Raises $69 Million Through ATM Equity Offering
Sana Biotechnology (SANA) sold 21.6 million shares through its at-the-market equity program, raising $69 million in net proceeds, the company said Friday.The proceeds, combined with a previously disclosed $25 million investment from the Mayo Clinic, bring the company's total capital raised since the end of Q1 to $94 million, extending its cash runway into mid-2027, the company added.Shares of Sana Biotechnology were down more than 5% in recent Friday trading.Price: $2.99, Change: $-0.16, Percent Change: -4.94%
$SANA
